Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ABBOTT LABORATORIES A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   3.3% 2.0% 2.0% 0.4% 0.4% 0.4% 7.1% 7.1%   Credit score (0-100)   56 70 69 100 100 100 34 34   Credit rating   BBB A A AAA AAA AAA BBB BBB   Credit limit (mDKK)   0.0 0.0 0.0 13.2 15.5 15.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   129 163 196 259 268 327 327 327   Gross profit   22.5 39.8 39.7 44.2 51.2 62.6 0.0 0.0   EBITDA   3.0 7.8 6.2 8.9 9.0 14.9 0.0 0.0   EBIT   3.0 7.8 6.2 7.7 8.0 13.3 0.0 0.0   Pre-tax profit (PTP)   -2.1 6.0 4.8 7.7 8.0 11.7 0.0 0.0   Net earnings   -2.1 6.0 4.8 6.0 6.1 9.2 0.0 0.0   Pre-tax profit without non-rec. items   3.0 7.8 6.2 7.7 8.0 11.7 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 4.9 5.0 12.3 0.0 0.0   Shareholders equity total   151 107 112 118 124 133 129 129   Interest-bearing liabilities   0.0 0.0 0.0 42.4 61.3 55.2 0.0 0.0   Balance sheet total (assets)   187 178 165 183 208 218 129 129   Net Debt   0.0 0.0 0.0 38.2 26.5 42.3 -129 -129     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   129 163 196 259 268 327 327 327   Net sales growth   -12.5% 26.3% 20.3% 32.3% 3.4% 22.1% 0.0% 0.0%   Gross profit   22.5 39.8 39.7 44.2 51.2 62.6 0.0 0.0   Gross profit growth   -34.6% 76.8% -0.1% 11.1% 15.9% 22.3% -100.0% 0.0%   Employees   0 0 0 39 44 50 0 0   Employee growth %   -100.0% 0.0% 0.0% 0.0% 12.8% 13.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   187 178 165 183 208 218 129 129   Balance sheet change%   126.4% -4.7% -7.8% 11.3% 13.3% 5.2% -40.9% 0.0%   Added value   3.0 7.8 6.2 8.9 9.3 14.9 0.0 0.0   Added value %   2.3% 4.8% 3.1% 3.4% 3.5% 4.5% 0.0% 0.0%   Investments   -3 0 0 4 -1 6 -12 0   Net sales trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   2.3% 4.8% 3.1% 3.4% 3.4% 4.5% 0.0% 0.0%   EBIT %   2.3% 4.8% 3.1% 3.0% 3.0% 4.1% 0.0% 0.0%   EBIT to gross profit (%)   13.3% 19.7% 15.5% 17.4% 15.7% 21.3% 0.0% 0.0%   Net Earnings %   -1.6% 3.7% 2.5% 2.3% 2.3% 2.8% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -1.6% 3.7% 2.5% 2.8% 2.6% 3.3% 0.0% 0.0%   Pre tax profit less extraordinaries %   2.3% 4.8% 3.1% 3.0% 3.0% 3.6% 0.0% 0.0%   ROA %   2.2% 4.3% 3.6% 4.5% 4.3% 6.5% 0.0% 0.0%   ROI %   2.4% 4.3% 3.6% 4.8% 4.8% 7.4% 0.0% 0.0%   ROE %   -2.0% 4.7% 4.4% 5.2% 5.1% 7.1% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   100.0% 100.0% 100.0% 65.0% 59.7% 62.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 24.6% 30.6% 25.4% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 22.9% 17.6% 21.5% -39.4% -39.4%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 429.0% 293.4% 284.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 36.0% 49.6% 41.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.9% 0.8% 3.8% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 1.2 1.1 1.1 0.0 0.0   Current Ratio   0.0 0.0 0.0 1.3 1.3 1.3 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 4.2 34.8 12.9 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 98.1 69.7 80.5 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 43.5 46.9 35.4 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 31.3% 39.3% 33.2% 39.4% 39.4%   Net working capital   0.0 0.0 0.0 17.5 23.3 25.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 6.8% 8.7% 7.8% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 7 6 7 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0